PDF File Link Is At The End Of Article 👇👇
Schizophrenia
Introduction
Schizophrenia is a severe, long-term mental disorder that affects how a person thinks, feels, and behaves. It is characterized by a breakdown in the relationship between thought, emotion, and reality, leading to significant impairment in daily functioning. Individuals with schizophrenia may appear disconnected from reality, experience hallucinations, or hold strong beliefs that are not based in reality.
Schizophrenia is not a split personality, as commonly misunderstood, but rather a disorder involving disturbances in perception, cognition, and emotional responsiveness.
Epidemiology
Schizophrenia affects approximately 1% of the global population. It occurs in all cultures and societies, with similar prevalence worldwide.
- Onset is typically in late adolescence or early adulthood
- Males tend to develop symptoms earlier (late teens to early 20s)
- Females often present later (mid-20s to early 30s)
- It is slightly more severe and has an earlier onset in males
Etiology
The exact cause of schizophrenia is unknown, but it is considered a multifactorial disorder involving a combination of genetic, biological, and environmental factors.
Genetic Factors
- Strong hereditary component
- Risk increases if a first-degree relative is affected
- Monozygotic twins have higher concordance rates than dizygotic twins
Neurochemical Factors
- Dopamine hypothesis: excess dopamine activity in certain brain pathways
- Glutamate dysfunction also plays a role
- Imbalance of neurotransmitters affects perception and cognition
Structural Brain Changes
- Enlarged ventricles
- Reduced gray matter
- Abnormalities in frontal and temporal lobes
Environmental Factors
- Prenatal infections or malnutrition
- Birth complications
- Early life stress or trauma
- Substance abuse (especially cannabis)
Pathophysiology
Schizophrenia involves complex interactions between neurotransmitters and brain circuits.
- Hyperactivity of dopamine in the mesolimbic pathway → positive symptoms
- Hypoactivity of dopamine in the mesocortical pathway → negative symptoms
- Glutamate dysfunction contributes to cognitive impairment
Brain imaging studies show altered connectivity between different brain regions, particularly those involved in thinking, memory, and emotional regulation.
Clinical Features
Positive Symptoms (Excess or Distortion of Normal Functions)
- Hallucinations (commonly auditory)
- Delusions (false, fixed beliefs)
- Disorganized speech
- Disorganized or bizarre behavior
Negative Symptoms (Loss of Normal Functions)
- Reduced emotional expression (flat affect)
- Lack of motivation (avolition)
- Social withdrawal
- Reduced speech (alogia)
Cognitive Symptoms
- Impaired attention
- Poor memory
- Difficulty in decision-making
- Reduced executive functioning
Types of Hallucinations
- Auditory: hearing voices (most common)
- Visual: seeing things that are not present
- Tactile: feeling sensations without stimulus
- Olfactory: smelling odors that are not real
- Gustatory: unusual taste perceptions
Types of Delusions
- Persecutory: belief of being harmed or targeted
- Grandiose: belief of having special powers or importance
- Referential: belief that events relate directly to oneself
- Somatic: belief of having a physical illness
- Thought insertion or withdrawal
Diagnostic Criteria
Diagnosis is primarily clinical and based on criteria such as those outlined in DSM-5.
Key requirements include:
- At least two major symptoms (one must be hallucinations, delusions, or disorganized speech)
- Symptoms present for at least 6 months
- Significant impairment in social or occupational functioning
Differential Diagnosis
- Bipolar disorder with psychotic features
- Major depressive disorder with psychosis
- Substance-induced psychosis
- Delirium
- Schizoaffective disorder
Investigations
There is no definitive laboratory test for schizophrenia, but investigations are done to rule out other conditions:
- Blood tests (to exclude metabolic or infectious causes)
- Urine toxicology (to rule out substance abuse)
- CT or MRI brain (to exclude structural abnormalities)
Management
Pharmacological Treatment
Antipsychotic Medications
- First-generation (typical): e.g., haloperidol
- Second-generation (atypical): e.g., risperidone, olanzapine
These medications primarily work by blocking dopamine receptors.
Side Effects
- Extrapyramidal symptoms (rigidity, tremors)
- Weight gain
- Sedation
- Metabolic syndrome
Psychological Therapies
- Cognitive Behavioral Therapy (CBT)
- Family therapy
- Social skills training
- Psychoeducation
Social Support
- Rehabilitation programs
- Supported employment
- Community mental health services
Course and Prognosis
The course of schizophrenia varies widely:
- Some patients experience episodic illness with recovery
- Others have chronic, progressive symptoms
- Early treatment improves outcomes
Prognosis depends on:
- Early diagnosis and treatment
- Medication adherence
- Family and social support
- Absence of substance abuse
Complications
- Suicide risk (significantly increased)
- Substance abuse
- Social isolation
- Homelessness
- Poor physical health
Risk Factors for Poor Outcome
- Early onset
- Male gender
- Poor social support
- Non-compliance with treatment
- Predominant negative symptoms
Prevention
There is no definite prevention, but risk can be reduced by:
- Early identification of symptoms
- Avoiding substance abuse
- Providing psychological support
- Managing stress
Insight and Awareness
Many patients with schizophrenia lack insight into their condition, meaning they may not recognize that they are ill. This contributes to poor treatment adherence and relapse.
Impact on Daily Life
Schizophrenia significantly affects:
- Work performance
- Relationships
- Self-care
- Decision-making ability
Patients often require long-term care and support to maintain functionality.
Stigma and Social Challenges
Individuals with schizophrenia often face stigma and discrimination, which can lead to:
- Delayed treatment
- Social withdrawal
- Reduced opportunities
Public education and awareness are essential to reduce stigma and improve quality of life for affected individuals.
Neurodevelopmental Perspective
Schizophrenia is increasingly viewed as a neurodevelopmental disorder:
- Abnormal brain development begins early in life
- Symptoms appear later when brain maturation occurs
- Environmental triggers may activate underlying vulnerability
Role of Family
Family plays a critical role in management:
- Emotional support improves outcomes
- Family therapy reduces relapse rates
- Education helps in recognizing early warning signs
Early Warning Signs (Prodromal Phase)
Before full symptoms develop, patients may show:
- Social withdrawal
- Decline in academic or work performance
- Odd beliefs or suspiciousness
- Reduced emotional expression
Early detection at this stage can prevent progression.
Detailed Pharmacological Management
First-Generation Antipsychotics (Typical)
These are older drugs primarily targeting dopamine D2 receptors.
- Examples: Haloperidol, Chlorpromazine
- Strong effect on positive symptoms
- Higher risk of extrapyramidal side effects (EPS)
Mechanism of Action
- Block dopamine receptors in the mesolimbic pathway
- Reduce hallucinations and delusions
Adverse Effects
- Acute dystonia
- Parkinsonism
- Akathisia (restlessness)
- Tardive dyskinesia (late, irreversible movements)
Second-Generation Antipsychotics (Atypical)
These are preferred due to better side-effect profiles.
- Examples: Risperidone, Olanzapine, Quetiapine, Clozapine
- Act on both dopamine and serotonin receptors
Advantages
- Better control of negative symptoms
- Lower risk of EPS
Side Effects
- Weight gain
- Diabetes mellitus
- Dyslipidemia
- Sedation
Clozapine – The Gold Standard for Resistant Cases
Clozapine is used in treatment-resistant schizophrenia.
Indications
- Failure of at least two antipsychotics
- High suicide risk
Important Risks
- Agranulocytosis (life-threatening drop in white blood cells)
- Requires regular blood monitoring
Long-Acting Injectable Antipsychotics
- Useful in non-compliant patients
- Examples: Haloperidol decanoate, Risperidone depot
These improve adherence and reduce relapse rates.
Management of Acute Psychotic Episode
Emergency Approach
In severely agitated or aggressive patients:
- Ensure patient and staff safety
- Use verbal de-escalation first
- Administer IM antipsychotics if needed (e.g., haloperidol)
- Benzodiazepines may be added for sedation
Treatment Phases
Acute Phase
- Goal: control psychotic symptoms
- Duration: weeks to months
Stabilization Phase
- Goal: prevent relapse and improve functioning
- Continue medication
Maintenance Phase
- Long-term therapy
- Prevent recurrence
Psychosocial Interventions
Cognitive Behavioral Therapy (CBT)
- Helps patients identify distorted thoughts
- Reduces distress from hallucinations
Family Therapy
- Educates family members
- Reduces relapse rates
Social Skills Training
- Improves communication and daily functioning
Rehabilitation Programs
- Focus on employment and independent living
Compliance and Adherence Issues
Non-adherence is common due to:
- Lack of insight
- Side effects
- Social stigma
Strategies to Improve Compliance
- Use long-acting injectables
- Psychoeducation
- Simplify medication regimens
- Strong doctor-patient relationship
Relapse and Recurrence
Common Causes
- Stopping medication
- Stressful life events
- Substance abuse
Early Signs of Relapse
- Sleep disturbances
- Irritability
- Suspiciousness
- Social withdrawal
Early intervention can prevent full relapse.
Suicide Risk in Schizophrenia
Patients with schizophrenia have a significantly increased risk of suicide.
Risk Factors
- Depression
- Previous suicide attempts
- Insight into illness
- Substance abuse
Prevention
- Close monitoring
- Treat depression
- Use of Clozapine (reduces suicide risk)
Substance Abuse and Schizophrenia
- Commonly associated with cannabis, alcohol, and nicotine
- Worsens symptoms
- Increases relapse risk
- Reduces treatment effectiveness
Special Populations
Schizophrenia in Children
- Rare but severe
- Poor prognosis
- Developmental delays common
Schizophrenia in Elderly
- Late-onset cases
- More paranoia
- Less severe negative symptoms
Neurocognitive Deficits
Patients may have impairments in:
- Attention
- Working memory
- Processing speed
- Executive function
These deficits significantly affect daily functioning.
Insight-Oriented Therapy
- Helps patients understand their illness
- Improves adherence
- Reduces relapse
Role of Dopamine Pathways
Schizophrenia symptoms are linked to specific dopamine pathways:
- Mesolimbic → positive symptoms
- Mesocortical → negative symptoms
- Nigrostriatal → movement side effects
- Tuberoinfundibular → hormonal effects
Extrapyramidal Side Effects (EPS)
Types
- Acute dystonia → muscle spasms
- Akathisia → restlessness
- Parkinsonism → tremor, rigidity
- Tardive dyskinesia → repetitive movements
Management
- Anticholinergics (e.g., benztropine)
- Dose reduction
- Switch to atypical antipsychotics
Neuroleptic Malignant Syndrome (NMS)
A life-threatening complication of antipsychotics.
Features
- Hyperthermia
- Muscle rigidity
- Altered mental status
- Autonomic instability
Management
- Stop antipsychotic immediately
- Supportive care
- Use dantrolene or bromocriptine
Metabolic Syndrome in Schizophrenia
Common with atypical antipsychotics:
- Obesity
- Hyperglycemia
- Hypertension
- Dyslipidemia
Regular monitoring is essential.
Role of Electroconvulsive Therapy (ECT)
Electroconvulsive Therapy may be used in:
- Severe or resistant cases
- Catatonia
- High suicide risk
Catatonic Schizophrenia
Features
- Immobility or excessive movement
- Mutism
- Waxy flexibility
- Echolalia (repeating words)
Treatment
- Benzodiazepines
- Electroconvulsive Therapy if severe
Cultural Considerations
- Symptoms may vary across cultures
- Hallucinations may be interpreted differently
- Cultural beliefs influence treatment-seeking behavior
Legal and Ethical Issues
- Involuntary admission in severe cases
- Patient autonomy vs safety
- Confidentiality
Brain Imaging Findings
- Enlarged lateral ventricles
- Reduced cortical thickness
- Hypofrontality (reduced frontal lobe activity)
Biomarkers and Research
- No definitive biomarker yet
- Research ongoing in genetics and neuroimaging
- Focus on early detection and prevention
Functional Outcomes
Schizophrenia affects:
- Employment
- Education
- Relationships
- Independent living
Long-term support is often required.
Ultra High-Yield Exam Points (Must-Know 🔥)
Core Diagnostic Triad
- Delusions
- Hallucinations (especially auditory)
- Disorganized speech
👉 If a question gives voices commenting or commanding, think immediately of Schizophrenia
Duration Rule (VERY IMPORTANT)
- ≥ 6 months total duration → Schizophrenia
- 1–6 months → Schizophreniform disorder
- < 1 month → Brief psychotic disorder
First-Rank Symptoms (Classic Exam Favorite)
- Thought insertion
- Thought withdrawal
- Thought broadcasting
- Voices discussing patient in third person
👉 These are highly suggestive of schizophrenia
Mnemonics
“4 A’s of Schizophrenia”
- Affect (flat)
- Autism (social withdrawal)
- Associations (loose/disorganized)
- Ambivalence
Positive vs Negative Symptoms
Positive = “Added”
- Delusions
- Hallucinations
- Disorganized behavior
Negative = “Lost”
- Avolition
- Alogia
- Anhedonia
- Flat affect
👉 Mnemonic for negative: “AAAA”
USMLE / Exam Traps ⚠️
Trap 1: Substance-Induced Psychosis
- Always check history of drug use (cannabis, amphetamines)
- If symptoms resolve after stopping → NOT schizophrenia
Trap 2: Mood Disorders
- Psychosis + mood episodes → think bipolar or depression with psychosis
- Pure psychosis without mood → schizophrenia
Trap 3: Delirium vs Schizophrenia
- Delirium → fluctuating consciousness
- Schizophrenia → clear consciousness
Trap 4: Sudden Onset
- Sudden psychosis → think brief psychotic disorder
- Schizophrenia is usually gradual
Clinical Case Scenarios
Case 1
A 22-year-old male hears voices commenting on his actions and believes people are spying on him for 8 months.
👉 Diagnosis: Schizophrenia
Case 2
A patient presents with psychosis for 3 weeks after severe stress.
👉 Diagnosis: Brief psychotic disorder
Case 3
A cannabis user develops hallucinations which disappear after stopping drugs.
👉 Diagnosis: Substance-induced psychosis
Case 4
Patient with depression + hallucinations only during depressive episodes.
👉 Diagnosis: Major depressive disorder with psychotic features
Drug-Based High-Yield Points
Which Drug Causes Least EPS?
👉 Clozapine
Which Drug Causes Most EPS?
👉 Haloperidol
Drug of Choice in Resistant Schizophrenia
👉 Clozapine
Dangerous Side Effect to Remember
- Clozapine → Agranulocytosis
👉 Always monitor WBC count
Rapid Revision Table
| Feature | Schizophrenia |
|---|---|
| Duration | ≥ 6 months |
| Core Symptoms | Delusions, hallucinations, disorganized speech |
| Insight | Poor |
| Treatment | Antipsychotics |
| Best Drug (resistant) | Clozapine |
| Suicide Risk | High |
Emergency Pearls 🚨
- Agitated patient → Haloperidol IM ± benzodiazepine
- Catatonia → Benzodiazepines or Electroconvulsive Therapy
- NMS → Stop drug immediately
Differentiation Table (SUPER IMPORTANT)
| Disorder | Duration | Key Feature |
|---|---|---|
| Brief psychotic | < 1 month | Sudden onset |
| Schizophreniform | 1–6 months | Same symptoms |
| Schizophrenia | > 6 months | Chronic |
| Schizoaffective | Psychosis + mood | Mixed |
High-Yield Lab & Imaging Points
- No specific diagnostic test
- CT/MRI → enlarged ventricles
- Rule out:
- Drugs
- Tumors
- Infections
Memory Tricks for Exams
👉 If question mentions:
- “Voices talking” → Schizophrenia
- “6 months” → Schizophrenia
- “Flat affect + withdrawal” → Negative symptoms
- “Clozapine” → Resistant + suicide prevention
Top 10 One-Liners (Exam Gold 💯)
- Schizophrenia = chronic psychotic disorder > 6 months
- Most common symptom = auditory hallucination
- First-line drugs = atypical antipsychotics
- Most dangerous drug side effect = agranulocytosis (clozapine)
- EPS = typical antipsychotics
- Suicide risk = high
- Insight = poor
- Negative symptoms = poor prognosis
- Dopamine ↑ → positive symptoms
- Dopamine ↓ → negative symptoms
Advanced Neurobiology of Schizophrenia
Schizophrenia is no longer viewed as a single-pathway disorder. Modern understanding shows it involves multiple neurotransmitter systems, neural circuits, and developmental abnormalities.
Dopamine Hypothesis (Refined Version)
Instead of a simple “dopamine excess,” schizophrenia involves region-specific imbalance:
1. Mesolimbic Pathway → Hyperdopaminergic
- Leads to positive symptoms
- Hallucinations and delusions
2. Mesocortical Pathway → Hypodopaminergic
- Leads to negative + cognitive symptoms
- Poor motivation, flat affect
3. Nigrostriatal Pathway
- Controls movement
- Blockade → EPS side effects
4. Tuberoinfundibular Pathway
- Regulates prolactin
- Dopamine blockade → hyperprolactinemia
- Galactorrhea
- Gynecomastia
Glutamate Hypothesis
- Reduced activity of NMDA receptors
- Leads to impaired synaptic signaling
- Explains cognitive deficits + negative symptoms
👉 Drugs like phencyclidine (PCP) block NMDA receptors and can mimic schizophrenia symptoms
Serotonin Involvement
- Increased serotonin (5-HT2A) activity
- Explains why atypical antipsychotics block both dopamine and serotonin receptors
Neurodevelopmental Model
Schizophrenia develops in stages:
Early Life (Silent Phase)
- Genetic vulnerability
- Abnormal brain wiring
Adolescence
- Synaptic pruning abnormalities
- Dopamine system dysregulation begins
Adulthood
- Full clinical symptoms appear
Structural Brain Changes
Key Findings
- Enlarged lateral ventricles
- Reduced gray matter
- Frontal lobe dysfunction (hypofrontality)
- Temporal lobe abnormalities
Functional Changes
- Reduced activity in prefrontal cortex
- Impaired connectivity between brain regions
- Abnormal information processing
Receptor-Level Pharmacology
D2 Receptor Blockade
All antipsychotics act primarily by:
- Blocking dopamine D2 receptors
- Reducing positive symptoms
👉 But excessive blockade → side effects
Serotonin-Dopamine Balance
Atypical antipsychotics:
- Block 5-HT2A receptors
- Indirectly increase dopamine in some areas
- Reduce EPS risk
Comparison: Typical vs Atypical Antipsychotics
| Feature | Typical | Atypical |
|---|---|---|
| Dopamine Block | Strong | Moderate |
| Serotonin Effect | Minimal | Strong |
| EPS Risk | High | Low |
| Negative Symptoms | Poor control | Better control |
Partial Dopamine Agonists
- Example: Aripiprazole
- Acts as dopamine stabilizer
👉 If dopamine high → blocks
👉 If dopamine low → stimulates
Treatment-Resistant Mechanisms
Some patients do not respond due to:
- Non-dopaminergic dysfunction
- Glutamate abnormalities
- Genetic differences
👉 This is why Clozapine is effective (acts on multiple receptors)
Clozapine – Advanced Mechanism
- Weak D2 blockade
- Strong 5-HT2A antagonism
- Affects glutamate pathways
👉 Also reduces suicide risk significantly
Side Effects Explained (Mechanism-Based)
EPS (Movement Disorders)
- Due to dopamine blockade in nigrostriatal pathway
Hyperprolactinemia
- Due to dopamine blockade in tuberoinfundibular pathway
Sedation
- Histamine (H1) receptor blockade
Weight Gain
- Histamine + serotonin effects
Orthostatic Hypotension
- Alpha-1 receptor blockade
Neuroinflammation Theory
- Increased inflammatory markers in brain
- Microglial activation
- May contribute to disease progression
Oxidative Stress
- Increased free radicals
- Neuronal damage
- Impaired brain function
Genetics and Molecular Biology
Key Points
- Polygenic disorder
- Multiple genes involved
Important Genes
- DISC1 (brain development)
- COMT (dopamine metabolism)
- Neuregulin
Endophenotypes (Intermediate Traits)
These are measurable traits seen in patients and relatives:
- Cognitive deficits
- Eye tracking abnormalities
- Working memory issues
Advanced Clinical Concepts
Insight Spectrum
- Complete denial → partial insight → full awareness
- Better insight sometimes ↑ depression risk
Expressed Emotion (EE)
High EE in families =
- Criticism
- Hostility
- Emotional over-involvement
👉 Leads to higher relapse rates
Long-Term Brain Changes
- Progressive gray matter loss
- Functional decline over time
- Cognitive deterioration
Future Treatments (Emerging Concepts)
- Glutamate modulators
- Anti-inflammatory drugs
- Cognitive enhancers
- Gene-based therapies
Ultra-Deep Exam Pearls
- Positive symptoms = dopamine excess (mesolimbic)
- Negative symptoms = dopamine deficiency (mesocortical)
- EPS = nigrostriatal blockade
- Prolactin ↑ = tuberoinfundibular blockade
Integration Concept (Big Picture)
Schizophrenia is a disorder of:
- Neurotransmitters (dopamine, glutamate, serotonin)
- Brain structure (gray matter loss)
- Brain function (connectivity issues)
- Development (early brain wiring problems)
👉 It is not just a chemical imbalance, but a whole-brain network disorder
Clinical Viva & OSCE Mastery (High-Yield 🧠)
How to Present a Case of Schizophrenia
👉 Standard Viva Format
Introduction:
- Name, age, gender
- Brought by family or self
- Presenting complaints
Example:
“A 24-year-old male presented with hearing voices and suspicious behavior for 8 months.”
History Taking (Step-by-Step)
1. Presenting Complaints
- Hallucinations
- Delusions
- Disorganized behavior
- Social withdrawal
2. History of Present Illness
Ask clearly:
- When did symptoms start?
- Gradual or sudden?
- Progression over time?
- Any triggers (stress, drugs)?
👉 Always ask about duration (6 months rule!)
3. Hallucination Assessment
Ask:
- “Do you hear voices?”
- “What do they say?”
- “Do they talk about you or give commands?”
⚠️ Command hallucinations = danger risk
4. Delusion Assessment
Ask gently:
- “Do you feel someone is watching or following you?”
- “Do you feel you have special powers?”
👉 Never directly say “This is false” (important OSCE behavior)
5. Negative Symptoms
- Loss of interest
- Reduced speech
- Social isolation
- Poor self-care
6. Cognitive Symptoms
- Poor attention
- Memory issues
- Difficulty planning
7. Risk Assessment 🚨
VERY IMPORTANT in exam:
- Suicide thoughts?
- Harm to others?
- Self-neglect?
8. Substance Use
- Cannabis
- Alcohol
- Amphetamines
👉 Always rule out drug-induced psychosis
9. Past Psychiatric History
- Previous episodes
- Hospitalizations
- Medication history
10. Family History
- Any psychiatric illness in family
Mental Status Examination (MSE)
Appearance
- Poor hygiene
- Odd dressing
Behavior
- Agitated / withdrawn
- Suspicious
Speech
- Disorganized
- Reduced
Mood & Affect
- Flat or inappropriate affect
Thought Process
- Loose associations
- Tangential thinking
Thought Content
- Delusions
Perception
- Hallucinations
Insight
- Usually poor
Judgment
- Impaired
OSCE Communication Skills 🎯
DOs ✅
- Be calm and non-judgmental
- Use simple language
- Show empathy
- Maintain eye contact
DON'Ts ❌
- Do not argue with delusions
- Do not confront directly
- Do not dismiss patient feelings
Golden Line for OSCE
👉 “I understand this feels very real to you.”
How to Differentiate in Viva (Examiner Trap)
Schizophrenia vs Bipolar Disorder
| Feature | Schizophrenia | Bipolar |
|---|---|---|
| Mood symptoms | Absent | Prominent |
| Psychosis | مستقل | Mood-related |
| Course | Chronic | Episodic |
Schizophrenia vs Depression with Psychosis
- Depression → low mood dominates
- Schizophrenia → psychosis dominates
Schizophrenia vs Delirium
- Delirium → fluctuating consciousness
- Schizophrenia → clear consciousness
OSCE Scenario Examples
Scenario 1: Aggressive Patient
👉 Approach:
- Ensure safety
- Keep distance
- Calm voice
- Call for help if needed
Scenario 2: Patient Hearing Voices
👉 Response:
- Acknowledge experience
- Ask details
- Assess risk
Scenario 3: Non-Compliant Patient
👉 Approach:
- Ask reason for stopping meds
- Explain importance
- Suggest long-acting injections
Examiner Favorite Questions
Q: Why poor compliance?
- Lack of insight
- Side effects
- Stigma
Q: Why suicide risk is high?
- Depression
- Command hallucinations
- Insight into illness
Q: Drug of choice in resistant case?
👉 Clozapine
Q: Most dangerous side effect of Clozapine?
👉 Agranulocytosis
Q: What to monitor?
👉 WBC count
Real-Life Clinical Approach
First Visit
- Build trust
- Do full assessment
- Start antipsychotic
Follow-Up
- Monitor symptoms
- Check side effects
- Ensure compliance
Long-Term Care
- Rehabilitation
- Family involvement
- Social support
Breaking Bad News (OSCE Skill)
Steps
- Prepare environment
- Assess patient understanding
- Deliver information gently
- Provide support
Red Flag Situations 🚨
- Command hallucinations
- Violent behavior
- Severe self-neglect
- Suicide thoughts
👉 Requires urgent intervention
Quick OSCE Summary
- Be calm
- Be empathetic
- Don’t challenge delusions
- Always assess risk
- Remember 6-month rule
Final Clinical Integration
In exam and real life:
- Diagnose based on history + duration
- Treat with antipsychotics + psychosocial care
- Always assess risk + compliance
Emergency Cases & Ward Management (Hospital-Level 🔥)
Emergency Case 1: Violent Psychotic Patient
A patient with Schizophrenia arrives agitated, shouting, and threatening staff.
Immediate Priorities
- Ensure safety of patient + staff
- Call for assistance
- Maintain safe distance
- Remove harmful objects
Stepwise Management
1. Verbal De-escalation
- Calm tone
- Simple commands
- Avoid confrontation
2. Chemical Restraint
👉 If patient not controlled:
- IM Haloperidol
- ± Benzodiazepine (e.g., lorazepam)
3. Physical Restraint (Last Resort)
- Only if necessary
- Continuous monitoring required
Emergency Case 2: Suicidal Patient
Red Flags 🚨
- Command hallucinations (“Kill yourself”)
- Severe depression
- Previous attempts
Management
- Immediate admission
- Close observation
- Remove dangerous items
- Start appropriate medication
👉 Clozapine reduces suicide risk
Emergency Case 3: Catatonia
Features
- Mutism
- Immobility
- Waxy flexibility
Treatment
- First-line: Benzodiazepines
- Severe cases: Electroconvulsive Therapy
Emergency Case 4: Neuroleptic Malignant Syndrome (NMS)
Life-Threatening Condition ⚠️
Symptoms
- High fever
- Muscle rigidity
- Confusion
- Autonomic instability
Management
- STOP antipsychotic immediately
- ICU care
- IV fluids
- Dantrolene / Bromocriptine
Ward Admission Protocol
Indications for Admission
- Danger to self or others
- Severe psychosis
- Non-compliance
- Lack of family support
Initial Ward Orders
Investigations
- CBC (especially WBC)
- LFTs, RFTs
- Blood glucose
- Urine toxicology
- ECG (before antipsychotics)
Baseline Monitoring
- Weight
- Blood pressure
- BMI
- Mental status
Drug Prescription Format (Exam Gold 💯)
Example Prescription
Drug: Risperidone
Dose: 2 mg
Route: Oral
Frequency: Once daily
Duration: As advised
Important Points
- Start low → go slow
- Titrate dose gradually
- Monitor side effects
Inpatient Daily Management
Daily Routine
- Mental status assessment
- Medication review
- Side effect monitoring
- Sleep evaluation
Nursing Care
- Ensure hygiene
- Monitor food intake
- Observe behavior
- Maintain safety
Managing Side Effects in Ward
EPS
- Add anticholinergic (e.g., benztropine)
Sedation
- Adjust dose timing
Weight Gain
- Diet + exercise advice
Discharge Planning
Before Discharge
- Symptoms controlled
- Patient stable
- Family educated
Discharge Advice
- Take medications regularly
- Avoid drugs/alcohol
- Regular follow-up
Follow-Up Protocol
First Follow-Up
- Within 1–2 weeks
Long-Term
- Monthly → then spaced out
Long-Acting Injectables (Depot Therapy)
When to Use
- Poor compliance
- Frequent relapse
Benefits
- Better adherence
- Reduced hospitalization
Rehabilitation & Social Reintegration
Goals
- Return to work
- Improve social skills
- Independent living
Methods
- Vocational training
- Counseling
- Community programs
Family Education (VERY IMPORTANT)
Teach Family
- Nature of illness
- Early warning signs
- Importance of medication
- Handling relapse
Relapse Prevention Strategy
- Continuous medication
- Stress management
- Avoid substance use
- Regular follow-up
Hospital-Level Clinical Pearls
- Never leave suicidal patient alone
- Always rule out organic causes
- Monitor vitals in acute cases
- Clozapine requires WBC monitoring
Prescription Writing OSCE Tips
- Always write generic name
- Mention dose, route, frequency
- Avoid abbreviations
Practical Ward Scenario
Case
A patient stops medication and returns with hallucinations.
👉 Management:
- Restart antipsychotic
- Consider depot injection
- Educate patient
Final Rapid Clinical Checklist ✅
- Safety first
- Assess risk
- Start antipsychotic
- Monitor side effects
- Ensure compliance
- Plan follow-up
.jpeg)
